Li Yan-Ming, Ma Xiu-Lan, Huang Shi-Qi, Wei Chun-Xin, Tan Guo-Wei, An Yao-Rong, Wang Xiao-Rong
Gansu University of Chinese Medicine Lanzhou 730000, China Gansu Key Laboratory of Excavation and Innovative Transformation of Traditional Chinese Medicine, Gansu Engineering Laboratory of Creation and Manufacturing of New Traditional Chinese Medicine Products Lanzhou 730000, China.
Zhongguo Zhong Yao Za Zhi. 2024 Jun;49(12):3373-3384. doi: 10.19540/j.cnki.cjcmm.20240221.502.
This study aims to explore the mechanism of Dabugan Decoction in the treatment of generalized anxiety disorder(GAD) based on network pharmacology, molecular docking, and animal experiments. Network pharmacology and molecular docking technology were used to obtain the possible targets and related signaling pathways of Dabugan Decoction in the treatment of GAD. The GAD rat model was established, and the corresponding drugs were given by gavage after randomization. After 28 days of continuous intervention, the anxiety state of rats was detected, and the pathological changes of the hippocampus were detected in each group. ELISA and Western blot were used to detect the protein expression levels of related molecules. A total of 65 drug compounds in Dabugan Decoction were obtained, involving 403 targets of action, 7 398 disease targets of GAD, and 279 common targets of "drug-disease". The key nodes in the protein-protein interaction(PPI) network were Akt1, TNF, IL-6, TP53, IL-1β, etc. Function analysis of Gene Ontology(GO) and enrichment analysis of Kyoto Encyclopedia of Genes and Genomes(KEGG) showed that the PI3K-Akt signaling pathway was the most important pathway. The results of molecular docking showed that the core components of the drug had good binding activity with the corresponding key targets. Animal experiments showed that Dabugan Decoction could effectively improve the anxiety behavior of rats and increase the open arm end movement distance and total distance of rats in the elevated cross labyrinth, the number and stay time of entering the open box, and the time(%) and the number of entering the center of the open field. At the same time, HE staining and Nicil staining showed that the number of hippocampal nerve cells in rats increased, and they were closely arranged. The damage to the cell body was improved, and there was an increase in Nissl substances in the cells. The expression of TNF-α, IL-6, and IL-1β in rat hippocampus decreased, and the expression of TP53, p-Akt1, and p-PI3K increased. The mechanism may be related to the activation of the PI3K-Akt signaling pathway and the inhibition of inflammatory response. Dabugan Decoction can play a good therapeutic and regulatory role in GAD, reflecting the overall effect of traditional Chinese medicine(TCM) compound and the characteristics of multiple targets and multiple pathways. At the same time, it is preliminarily discussed that the state of GAD may be improved by Dabugan Decoction via-activating PI3K-Akt signaling pathway and inhibiting inflammatory response and anti-apoptosis, thus providing experimental data support for the clinical application of Dabugan Decoction.
本研究旨在基于网络药理学、分子对接和动物实验,探索大补肝汤治疗广泛性焦虑障碍(GAD)的作用机制。运用网络药理学和分子对接技术,获取大补肝汤治疗GAD的潜在靶点及相关信号通路。建立GAD大鼠模型,随机分组后进行相应药物灌胃。连续干预28天后,检测大鼠的焦虑状态,并观察各组大鼠海马组织的病理变化。采用ELISA和Western blot检测相关分子的蛋白表达水平。大补肝汤中共得到65种药物化合物,涉及403个作用靶点、7398个GAD疾病靶点以及279个“药物-疾病”共同靶点。蛋白质-蛋白质相互作用(PPI)网络中的关键节点有Akt1、TNF、IL-6、TP53、IL-1β等。基因本体(GO)功能分析和京都基因与基因组百科全书(KEGG)富集分析表明,PI3K-Akt信号通路是最重要的信号通路。分子对接结果显示,该药物的核心成分与相应关键靶点具有良好的结合活性。动物实验表明,大补肝汤可有效改善大鼠的焦虑行为,增加大鼠在高架十字迷宫中的开臂端移动距离和总距离、进入开放箱的次数和停留时间、在旷场实验中进入中央区域的时间(%)和次数。同时,HE染色和尼氏染色显示,大鼠海马神经细胞数量增加,排列紧密,细胞体损伤得到改善,细胞内尼氏体增多。大鼠海马中TNF-α、IL-6和IL-1β的表达降低,TP53、p-Akt1和p-PI3K的表达增加。其机制可能与激活PI3K-Akt信号通路、抑制炎症反应有关。大补肝汤对GAD具有良好的治疗和调节作用,体现了中药复方的整体效应以及多靶点、多途径的特点。同时,初步探讨了大补肝汤可能通过激活PI3K-Akt信号通路、抑制炎症反应和抗凋亡来改善GAD状态,为大补肝汤的临床应用提供实验数据支持。